SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017933
Filing Date
2019-11-19
Accepted
2019-11-19 13:49:07
Documents
38
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 279385
2 ex31-1.htm EX-31.1 20163
3 ex31-2.htm EX-31.2 15483
4 ex32-1.htm EX-32.1 6680
  Complete submission text file 0001493152-19-017933.txt   2083293

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE iaso-20190930.xml EX-101.INS 251600
6 XBRL SCHEMA FILE iaso-20190930.xsd EX-101.SCH 35073
7 XBRL CALCULATION FILE iaso-20190930_cal.xml EX-101.CAL 26096
8 XBRL DEFINITION FILE iaso-20190930_def.xml EX-101.DEF 119692
9 XBRL LABEL FILE iaso-20190930_lab.xml EX-101.LAB 223562
10 XBRL PRESENTATION FILE iaso-20190930_pre.xml EX-101.PRE 161126
Mailing Address 7315 E. PEAKVIEW AVE. CENTENNIAL CO 80111
Business Address 7315 E. PEAKVIEW AVE. CENTENNIAL CO 80111 (303) 796-8940
IASO BioMed, Inc. (Filer) CIK: 0001662907 (see all company filings)

IRS No.: 473474169 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-215083 | Film No.: 191230443
SIC: 2834 Pharmaceutical Preparations